Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Warsaw - Delayed Quote PLN

Mabion S.A. (MAB.WA)

11.40
-0.10
(-0.87%)
As of 10:16:26 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in PLN.
NameTitlePayExercisedYear Born
Mr. Krzysztof Kaczmarczyk CEO & President of Management Board 875.45k -- --
Mr. Grzegorz Grabowicz CFO, Financial Director & Member of Management Board 554.32k -- 1973
Dr. Slawomir Jaros EMBA, Eng., Ph.D. Member of the Management Board & Scientific and Quality Director 553.68k -- --
Mr. Adam Pietruszkiewicz Member of Management Board & Business Development Director 574.62k -- --
Ms. Julita Balcerek M.D. Member of the Management Board, Operations Director & COO 557.71k -- --
Aneta Turek Chief Accountant -- -- --
Pawel Pobiedzinski Head of Logistics & Procurement -- -- --
Joanna Krolasik Head of Microbiology Laboratory -- -- --

Mabion S.A.

ul. gen. Mariana Langiewicza 60
Konstantynów Lódzki, 95-050
Poland
48 42 207 7890 https://www.mabion.eu
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
241

Description

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. Mabion S.A. was founded in 2007 and is based in Konstantynów Lódzki, Poland.

Corporate Governance

Mabion S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 27, 2025 at 10:59 AM UTC

Mabion S.A. Earnings Date

Recent Events

Related Tickers